| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.3 |